Eli Lilly and Company (NYSE:LLY), a United States-based pharmaceutical company, announced on Friday the retirement of Philip Johnson from the position of group vice president and treasurer.
Johnson is retiring from the company at the end of February to pursue a new professional opportunity. The successor to Johnson will be revealed at a future date.
Johnson headed the company's investor relations group for 11 years and was consistently named Top Investor Relations Officer by Institutional Investor. He worked as the company's treasurer since 2018 and has headed the firm's efforts within the financial community to drive positive social and economic change for underrepresented groups.
MemorialCare hospitals recognised in 2026 Women's Choice Awards
Champions Oncology expands bioanalytical services with new technology and leadership
PhaseV receives three industry honours for AI in clinical development
Galapagos plans to wind down cell therapy business following strategic review
Sebela's MIUDELLA Hormone-Free Copper IUS recognised in TIME's best inventions of 2025
Revelation Pharma acquires Acacia Apothecary & Wellness
Viatris receives fifth consecutive recognition on Forbes' annual list of World's Best Employers
AbbVie's Allergan Aesthetics announces Natrelle supplier agreement with Vizient
Karyopharm Therapeutics awards inducement grants to new employees
POLYTECH Health & Aesthetics announces Poland expansion
Santhera Pharmaceuticals signs Gulf region distribution agreement with Uniphar
Novo Nordisk expands legal action over compounded 'semaglutide'